Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to produce the treatment for more patients.
from NYT > Health https://ift.tt/PJ5A8sK
Subscribe to:
Post Comments (Atom)
Rose
0 comments:
Post a Comment